Partners and Supporters

PBI is grateful for the support of our donors, partners and collaborators who are helping us in our mission to prevent, treat and cure blood disorders.

Partner with PBI

Donors

Caruso Family, also supporting the Caruso Family Post-Doctoral Fellowship
Thomas Lang
Robert Pearson Family, supporting the Robert Pearson Scholarship & Research Fund
John Roberts and Family, supporting the Jan Roberts Biomedical Scholarship
Wheatley Family Foundation

Research Partners

Boehringer Ingelheim
Bristol-Myers Squibb
Takeda

Event Partners

Roche

Education Partners

Alexion
Amgen Australia
CSL Behring
Pfizer

PBI Collaborators

Latest

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab (Cancer - Recruitment: OPEN)

A Phase 1/2, Dose Escalation and Expansion Study of BGB-10188, a Phosphatidylinositol 3-Kinase Delta (PI3Kδ) Inhibitor, Combined With Zanubrutinib in Patients With Mature B-Cell Malignancies and Combined With Tislelizumab in Patients With Solid Tumors.
Create your #Thirty4Thrombosis fundraising page!

Information on how to set up a fundraising page for the Thirty4Thrombosis appeal.
Thirty4Thrombosis Appeal

Thrombosis is a potentially serious condition that involves a blood clot forming in a blood vessel, usually in the deep veins of the leg. Sitting for many hours can double your risk of thrombosis. Join our 30-day exercise challenge and get your body moving while you are working! Funds raised will help PBI to promote the importance of exercise to minimise the risk of developing deep vein thrombosis!
COVID-19 and Thrombosis: Information for Professionals

The landscape of managing patients with COVID-19 continues to change. New research suggests acute medical illness, such as COVID-19, and hospitalisation confer a greater risk of venous thromboembolism (VTE). Also, Coagulopathy in COVID-19 patients appears to be associated with poor prognosis, an effect common in patients with sepsis.

Accessibility
Privacy Policy

THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.
Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
COVID-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
Terms and Conditions
Create your #Thirty4Thrombosis fundraising page!

Information on how to set up a fundraising page for the Thirty4Thrombosis appeal.
COVID-19 Procedures

Information for current/prospective clinical trials patients regarding our COVID-19 procedures.
Make a bequest
Pancreatic Cancer study published

Pancreatic cancer is one of the deadliest diseases. A recent study led by PBI Scientist Dr Omar Elaskalani has been published in a special issue of Cancers by MDPI, a peer-reviewed academic journal. The study offers promising evidence that a commonly used blood thinner may help pancreatic cancer patients.
Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists.

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise